Recovering Your Investment: How to Take Action on the Regeneron Pharmaceuticals Inc. (REGN) Investigation – A Guide by Levi & Korsinsky
Levi & Korsinsky Investigates Regeneron Pharmaceuticals, Inc. for Possible Securities Violations Overview New York, NY / ACCESSWIRE / December 6, 2024 / Levi & Korsinsky has recently initiated an investigation into Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for potential breaches of federal securities laws. This investigation comes in the wake of Regeneron’s release of its third quarter…